{ "instance": { "fs42021a4_amplitudehlth.htm": { "axisCustom": 1, "axisStandard": 9, "contextCount": 205, "dts": { "calculationLink": { "local": [ "amhc-20210630_cal.xml" ] }, "definitionLink": { "local": [ "amhc-20210630_def.xml" ] }, "inline": { "local": [ "fs42021a4_amplitudehlth.htm" ] }, "labelLink": { "local": [ "amhc-20210630_lab.xml" ], "remote": [ "https://xbrl.fasb.org/srt/2021/elts/srt-doc-2021-01-31.xml", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml" ] }, "presentationLink": { "local": [ "amhc-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml", "https://xbrl.fasb.org/srt/2021/elts/srt-ref-2021-01-31.xml" ] }, "schema": { "local": [ "amhc-20210630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd" ] } }, "elementCount": 374, "entityCount": 1, "hidden": { "http://Amplitudehealthcare.com/20210630": 40, "http://fasb.org/us-gaap/2021-01-31": 76, "http://xbrl.sec.gov/dei/2021": 4, "total": 120 }, "keyCustom": 82, "keyStandard": 244, "memberCustom": 11, "memberStandard": 15, "nsprefix": "amhc", "nsuri": "http://Amplitudehealthcare.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AmendmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AmendmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Summary of Significant Accounting Policies", "role": "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Initial Public Offering", "role": "http://Amplitudehealthcare.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Private Placement", "role": "http://Amplitudehealthcare.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Related Party Transactions", "role": "http://Amplitudehealthcare.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Commitments and Contingencies", "role": "http://Amplitudehealthcare.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Stockholders' Equity", "role": "http://Amplitudehealthcare.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:WarrantLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Warrant Liabilities", "role": "http://Amplitudehealthcare.com/role/WarrantLiabilities", "shortName": "Warrant Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:WarrantLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Income Tax", "role": "http://Amplitudehealthcare.com/role/IncomeTax", "shortName": "Income Tax", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Fair Value Measurements", "role": "http://Amplitudehealthcare.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Subsequent Events", "role": "http://Amplitudehealthcare.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "role": "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidTaxes", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:RestatementToPriorYearBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Restatement of Previously Issued Financial Statements (Tables)", "role": "http://Amplitudehealthcare.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables", "shortName": "Restatement of Previously Issued Financial Statements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "amhc:RestatementToPriorYearBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Income Tax (Tables)", "role": "http://Amplitudehealthcare.com/role/IncomeTaxTables", "shortName": "Income Tax (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Fair Value Measurements (Tables)", "role": "http://Amplitudehealthcare.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c171", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Description of Organization and Business Operations (Details)", "role": "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "shortName": "Description of Organization and Business Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c171", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c108", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued balance sheet", "role": "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable", "shortName": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued balance sheet", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c108", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "amhc:ScheduleOfRestatementOfPreviouslyIssuedStatementOfOperationsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c117", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of operations", "role": "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable", "shortName": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of operations", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "amhc:ScheduleOfRestatementOfPreviouslyIssuedStatementOfOperationsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c117", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "amhc:ScheduleOfRestatementOfPreviouslyIssuedStatementOfCashFlowsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c114", "decimals": "0", "first": true, "lang": null, "name": "amhc:ChangeInFairValuesOfWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of cash flows", "role": "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable", "shortName": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of cash flows", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "amhc:ScheduleOfRestatementOfPreviouslyIssuedStatementOfCashFlowsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c114", "decimals": "0", "first": true, "lang": null, "name": "amhc:ChangeInFairValuesOfWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c1", "decimals": "INF", "first": true, "lang": null, "name": "amhc:CommonStockSubjectToPossibleRedemptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c1", "decimals": "INF", "first": true, "lang": null, "name": "amhc:CommonStockSubjectToPossibleRedemptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c8", "decimals": "2", "lang": null, "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "amhc:InterestIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common share", "role": "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "amhc:InterestIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Initial Public Offering (Details)", "role": "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails", "shortName": "Initial Public Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c178", "decimals": "2", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c172", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Private Placement (Details)", "role": "http://Amplitudehealthcare.com/role/PrivatePlacementDetails", "shortName": "Private Placement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c179", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c145", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Related Party Transactions (Details)", "role": "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c145", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForUnderwritingExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Commitments and Contingencies (Details)", "role": "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c188", "decimals": "-5", "lang": null, "name": "amhc:AggregateGrossProceeds", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Stockholders' Equity (Details)", "role": "http://Amplitudehealthcare.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c181", "decimals": "2", "lang": null, "name": "amhc:StockConversionPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Warrant Liabilities (Details)", "role": "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails", "shortName": "Warrant Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Income Tax (Details)", "role": "http://Amplitudehealthcare.com/role/IncomeTaxDetails", "shortName": "Income Tax (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "amhc:OrganizationalCostsStartupExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Income Tax (Details) - Schedule of net deferred tax assets", "role": "http://Amplitudehealthcare.com/role/ScheduleofnetdeferredtaxassetsTable", "shortName": "Income Tax (Details) - Schedule of net deferred tax assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "amhc:OrganizationalCostsStartupExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Income Tax (Details) - Schedule of income tax provision", "role": "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable", "shortName": "Income Tax (Details) - Schedule of income tax provision", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c16", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c16", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Income Tax (Details) - Schedule of federal income tax rate", "role": "http://Amplitudehealthcare.com/role/ScheduleoffederalincometaxrateTable", "shortName": "Income Tax (Details) - Schedule of federal income tax rate", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherInterestEarningAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Fair Value Measurements (Details)", "role": "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherInterestEarningAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Fair Value Measurements (Details) - Schedule of measured at fair value on a recurring basis", "role": "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable", "shortName": "Fair Value Measurements (Details) - Schedule of measured at fair value on a recurring basis", "subGroupType": "details", "uniqueAnchor": null }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "amhc:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements", "role": "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable", "shortName": "Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c137", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LiabilitiesFairValueDisclosure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities", "role": "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "shortName": "Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c160", "decimals": "0", "lang": null, "name": "amhc:FairValueOfInitialMeasurement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c169", "decimals": "INF", "first": true, "lang": null, "name": "amhc:AggregateSharesOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Subsequent Events (Details)", "role": "http://Amplitudehealthcare.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c169", "decimals": "INF", "first": true, "lang": null, "name": "amhc:AggregateSharesOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c16", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NoninterestIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common share", "role": "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c16", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NoninterestIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c7", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Fair Value Measurements (Details) - Schedule of measured at fair value on a recurring basis", "role": "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable0", "shortName": "Fair Value Measurements (Details) - Schedule of measured at fair value on a recurring basis", "subGroupType": "details", "uniqueAnchor": null }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "amhc:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements", "role": "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable0", "shortName": "Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c197", "decimals": "0", "first": true, "lang": null, "name": "amhc:FairValueAdjustmentOfWarrant", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities", "role": "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0", "shortName": "Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c173", "decimals": "0", "lang": null, "name": "amhc:FairValueAdjustmentOfWarrant", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c33", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "role": "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c33", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "INF", "first": true, "lang": null, "name": "amhc:SaleOfUnitsNetOfUnderwritingDiscountAndOfferingCost", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) (Parentheticals)", "role": "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3_Parentheticals", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "INF", "first": true, "lang": null, "name": "amhc:SaleOfUnitsNetOfUnderwritingDiscountAndOfferingCost", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c11", "decimals": "0", "lang": null, "name": "amhc:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Description of Organization and Business Operations", "role": "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperations", "shortName": "Description of Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Restatement of Previously Issued Financial Statements", "role": "http://Amplitudehealthcare.com/role/RestatementofPreviouslyIssuedFinancialStatements", "shortName": "Restatement of Previously Issued Financial Statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "fs42021a4_amplitudehlth.htm", "contextRef": "c10", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 27, "tag": { "amhc_AggregateCashProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate cash proceeds.", "label": "AggregateCashProceeds", "terseLabel": "Aggregate Cash Proceeds" } } }, "localname": "AggregateCashProceeds", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "amhc_AggregateGrossProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate Gross Proceeds.", "label": "AggregateGrossProceeds", "terseLabel": "Aggregate gross proceeds" } } }, "localname": "AggregateGrossProceeds", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "amhc_AggregatePerSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate Per Share Price.", "label": "AggregatePerSharePrice", "terseLabel": "Aggregate price (in Dollars per share)" } } }, "localname": "AggregatePerSharePrice", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "perShareItemType" }, "amhc_AggregatePublicSharePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate Public Share percentage.", "label": "AggregatePublicSharePercentage", "terseLabel": "Aggregate public share percentage" } } }, "localname": "AggregatePublicSharePercentage", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "amhc_AggregateSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of aggregate shares of common stock.", "label": "AggregateSharesOfCommonStock", "terseLabel": "Aggregate of shares of common stock (in Shares)", "verboseLabel": "Aggregate shares of common stock" } } }, "localname": "AggregateSharesOfCommonStock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "amhc_AsRestatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AsRestatedMember", "terseLabel": "As Restated [Member]" } } }, "localname": "AsRestatedMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "domainItemType" }, "amhc_AssetsAbstract00": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AssetsAbstract00", "terseLabel": "Assets:" } } }, "localname": "AssetsAbstract00", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable" ], "xbrltype": "stringItemType" }, "amhc_AssetsAbstract000": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AssetsAbstract000", "terseLabel": "Assets:" } } }, "localname": "AssetsAbstract000", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable0" ], "xbrltype": "stringItemType" }, "amhc_BasicAndDilutedNetLossPerShareClassBinDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "BasicAndDilutedNetLossPerShareClassBinDollarsPerShare", "terseLabel": "Basic and diluted net loss per share, Class B (in Dollars per share)" } } }, "localname": "BasicAndDilutedNetLossPerShareClassBinDollarsPerShare", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "perShareItemType" }, "amhc_BusinessCombinationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination description.", "label": "BusinessCombinationDescription", "terseLabel": "Business combination description" } } }, "localname": "BusinessCombinationDescription", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "amhc_BusinessCombinationOfWorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "business combination of working capital.", "label": "BusinessCombinationOfWorkingCapital", "terseLabel": "Business combination of working capital" } } }, "localname": "BusinessCombinationOfWorkingCapital", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "amhc_CashPaidForIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for income taxes.", "label": "CashPaidForIncomeTaxes", "terseLabel": "Cash paid for income taxes" } } }, "localname": "CashPaidForIncomeTaxes", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_CashUnderwritingDiscountPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "cash underwriting discount.", "label": "CashUnderwritingDiscountPerShare", "terseLabel": "Cash underwriting discount of per unit (in Dollars per share)" } } }, "localname": "CashUnderwritingDiscountPerShare", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "perShareItemType" }, "amhc_CashWithdrawnFromTrustAccountToPayForFranchiseTaxes": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "CashWithdrawnFromTrustAccountToPayForFranchiseTaxes.", "label": "CashWithdrawnFromTrustAccountToPayForFranchiseTaxes", "terseLabel": "Cash withdrawn from Trust Account to pay for taxes and franchise fees" } } }, "localname": "CashWithdrawnFromTrustAccountToPayForFranchiseTaxes", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_CashWithdrawnFromTrustAccountToPayForTaxes": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The Amount of Cash withdrawn from Trust Account to pay for taxes", "label": "CashWithdrawnFromTrustAccountToPayForTaxes", "negatedLabel": "Investment of cash into Trust Account" } } }, "localname": "CashWithdrawnFromTrustAccountToPayForTaxes", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_ChangeInFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value.", "label": "ChangeInFairValue", "terseLabel": "Change in fair value" } } }, "localname": "ChangeInFairValue", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0" ], "xbrltype": "monetaryItemType" }, "amhc_ChangeInFairValueOfWarrantLiability": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of change in fair value of warrant liability.", "label": "ChangeInFairValueOfWarrantLiability", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "ChangeInFairValueOfWarrantLiability", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "amhc_ChangeInFairValues": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair values.", "label": "ChangeInFairValues", "terseLabel": "Change in fair value" } } }, "localname": "ChangeInFairValues", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "amhc_ChangeInFairValuesOfWarrantLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of warrant liability.", "label": "ChangeInFairValuesOfWarrantLiability", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "ChangeInFairValuesOfWarrantLiability", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable" ], "xbrltype": "monetaryItemType" }, "amhc_ChangeInValueOfClassACommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInValueOfClassACommonStockSubjectToPossibleRedemption", "terseLabel": "Change in value of Class A common stock subject to possible redemption" } } }, "localname": "ChangeInValueOfClassACommonStockSubjectToPossibleRedemption", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "amhc_ChangeInValueOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInValueOfCommonStockSubjectToPossibleRedemption", "terseLabel": "Change in value of Class A common stock subject to possible redemption" } } }, "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "amhc_ChangeInValuesOfClassACommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in value of Class A common stock subject to possible redemption.", "label": "ChangeInValuesOfClassACommonStockSubjectToPossibleRedemption", "terseLabel": "Change in value of Class A common stock subject to possible redemption" } } }, "localname": "ChangeInValuesOfClassACommonStockSubjectToPossibleRedemption", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable" ], "xbrltype": "monetaryItemType" }, "amhc_ClassACommonStockSubjectToPossibleRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ClassACommonStockSubjectToPossibleRedemptionAbstract", "terseLabel": "Class A common stock subject to possible redemption" } } }, "localname": "ClassACommonStockSubjectToPossibleRedemptionAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "stringItemType" }, "amhc_ClassACommonStockSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class A Common Stock Subject to Possible Redemption.", "label": "ClassACommonStockSubjectToPossibleRedemptionPolicyTextBlock", "terseLabel": "Class A Common Stock Subject to Possible Redemption" } } }, "localname": "ClassACommonStockSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "amhc_ClassARedeemableCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ClassARedeemableCommonStockMember", "terseLabel": "Class A Redeemable Common Stock" } } }, "localname": "ClassARedeemableCommonStockMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "domainItemType" }, "amhc_ClassBNonRedeemableCommonstockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ClassBNonRedeemableCommonstockMember", "terseLabel": "Class B Non-Redeemable Common Stock" } } }, "localname": "ClassBNonRedeemableCommonstockMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "domainItemType" }, "amhc_CommitmentsandContingenciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "localname": "CommitmentsandContingenciesDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "amhc_CommitmentsandContingenciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "localname": "CommitmentsandContingenciesDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "amhc_CommonStockSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CommonStockSubjectToForfeiture", "terseLabel": "Common stock subject to forfeiture (in Shares)" } } }, "localname": "CommonStockSubjectToForfeiture", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "amhc_CommonStockSubjectToPossibleRedemptions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CommonStockSubjectToPossibleRedemptions", "terseLabel": "Common stock subject to possible redemption (in Shares)" } } }, "localname": "CommonStockSubjectToPossibleRedemptions", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "amhc_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConsultingAgreementMember", "terseLabel": "Consulting agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "amhc_DeferredOffingCostsPaidDirectlyBySponsorInExchangeForIssuanceOfClassBCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred offing costs paid directly by Sponsor in exchange for issuance of Class B common stock.", "label": "DeferredOffingCostsPaidDirectlyBySponsorInExchangeForIssuanceOfClassBCommonStock", "terseLabel": "Deferred offering costs paid directly by stockholder in exchange for issuance of Class B common stock" } } }, "localname": "DeferredOffingCostsPaidDirectlyBySponsorInExchangeForIssuanceOfClassBCommonStock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_DeferredTaxAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The Amount of Deferred Tax Asset", "label": "DeferredTaxAsset", "terseLabel": "Deferred tax asset" } } }, "localname": "DeferredTaxAsset", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "amhc_DeferredTaxAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DeferredTaxAssetAbstract", "terseLabel": "Deferred tax asset" } } }, "localname": "DeferredTaxAssetAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofnetdeferredtaxassetsTable" ], "xbrltype": "stringItemType" }, "amhc_DeferredTaxAssetValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DeferredTaxAssetValuationAllowance", "terseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetValuationAllowance", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "amhc_DeferredUnderwritingFeePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred underwriting fee payable.", "label": "DeferredUnderwritingFeePayable", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeePayable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_DeferredUnderwritingFeesPayable": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fee payable.", "label": "DeferredUnderwritingFeesPayable", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeesPayable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "amhc_DenominatorWeightedAverageNonRedeemableBCommonStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DenominatorWeightedAverageNonRedeemableBCommonStockAbstract", "terseLabel": "Denominator: Weighted Average Non-Redeemable B Common Stock" } } }, "localname": "DenominatorWeightedAverageNonRedeemableBCommonStockAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "stringItemType" }, "amhc_DenominatorWeightedAverageNonRedeemableClassBCommonStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DenominatorWeightedAverageNonRedeemableClassBCommonStockAbstract", "terseLabel": "Denominator: Weighted Average Non-Redeemable Class B Common Stock" } } }, "localname": "DenominatorWeightedAverageNonRedeemableClassBCommonStockAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "amhc_DenominatorWeightedAverageRedeemableClassACommonStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DenominatorWeightedAverageRedeemableClassACommonStockAbstract", "terseLabel": "Denominator: Weighted Average Redeemable Class A Common Stock" } } }, "localname": "DenominatorWeightedAverageRedeemableClassACommonStockAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "amhc_DenominatorWeightedAverageRedeemableClassACommonStockAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DenominatorWeightedAverageRedeemableClassACommonStockAbstract0", "terseLabel": "Denominator: Weighted Average Redeemable Class A Common Stock" } } }, "localname": "DenominatorWeightedAverageRedeemableClassACommonStockAbstract0", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "stringItemType" }, "amhc_DescriptionOfWarrantsForRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DescriptionOfWarrantsForRedemption", "terseLabel": "Description of warrants for redemption" } } }, "localname": "DescriptionOfWarrantsForRedemption", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "amhc_DescriptionofOrganizationandBusinessOperationsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Organization and Business Operations (Details) [Line Items]" } } }, "localname": "DescriptionofOrganizationandBusinessOperationsDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "amhc_DescriptionofOrganizationandBusinessOperationsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Organization and Business Operations (Details) [Table]" } } }, "localname": "DescriptionofOrganizationandBusinessOperationsDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "amhc_DissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dissolution expenses", "label": "DissolutionExpenses", "terseLabel": "Dissolution expenses" } } }, "localname": "DissolutionExpenses", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "amhc_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_EarningsBasicAndDilutedRedeemableClassACommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of earnings basic and diluted redeemable common stock.", "label": "EarningsBasicAndDilutedRedeemableClassACommonStock", "terseLabel": "Earnings/Basic and Diluted Redeemable Class A Common Stock" } } }, "localname": "EarningsBasicAndDilutedRedeemableClassACommonStock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "monetaryItemType" }, "amhc_EarningsBasicAndDilutedRedeemablesClassACommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EarningsBasicAndDilutedRedeemablesClassACommonStock", "terseLabel": "Earnings/Basic and Diluted Redeemable Class A Common Stock (in Dollars per share)" } } }, "localname": "EarningsBasicAndDilutedRedeemablesClassACommonStock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "perShareItemType" }, "amhc_EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantLiabilityinDollars": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and Transaction costs allocated to warrant liability.", "label": "EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantLiabilityinDollars", "terseLabel": "Transaction costs allocated to warrant liability" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantLiabilityinDollars", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleoffederalincometaxrateTable" ], "xbrltype": "percentItemType" }, "amhc_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EmergingGrowthCompanyPolicyTextBlock", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "amhc_FairValueAdjustmentOfWarrant": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of January 1, 2021.", "label": "FairValueAdjustmentOfWarrant", "periodEndLabel": "Fair value", "periodStartLabel": "Fair value" } } }, "localname": "FairValueAdjustmentOfWarrant", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0" ], "xbrltype": "monetaryItemType" }, "amhc_FairValueMeasurementsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Line Items]" } } }, "localname": "FairValueMeasurementsDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "amhc_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofLevel3warrantliabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities [Line Items]" } } }, "localname": "FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofLevel3warrantliabilitiesLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0" ], "xbrltype": "stringItemType" }, "amhc_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities [Table]" } } }, "localname": "FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0" ], "xbrltype": "stringItemType" }, "amhc_FairValueMeasurementsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Table]" } } }, "localname": "FairValueMeasurementsDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "amhc_FairValueOfAmountTransferToLevel1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of amount transfer to level 1.", "label": "FairValueOfAmountTransferToLevel1", "terseLabel": "Transfer to Level 1" } } }, "localname": "FairValueOfAmountTransferToLevel1", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "amhc_FairValueOfInitialMeasurement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of initial measurement.", "label": "FairValueOfInitialMeasurement", "terseLabel": "Initial measurement on November 22, 2019" } } }, "localname": "FairValueOfInitialMeasurement", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "amhc_FederalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FederalAbstract", "terseLabel": "Federal" } } }, "localname": "FederalAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "stringItemType" }, "amhc_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FounderSharesMember", "terseLabel": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "amhc_FranchiseAndIncomeTaxObligationsPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Franchise and income tax obligations paid.", "label": "FranchiseAndIncomeTaxObligationsPaid", "terseLabel": "Franchise and income tax obligations paid" } } }, "localname": "FranchiseAndIncomeTaxObligationsPaid", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "amhc_IncomeAndFranchiseTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income and Franchise Tax.", "label": "IncomeAndFranchiseTax", "negatedLabel": "Income and Franchise Tax" } } }, "localname": "IncomeAndFranchiseTax", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "monetaryItemType" }, "amhc_InitialClassificationOfClassACommonStockSubjectToPossibleRedemptioninShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InitialClassificationOfClassACommonStockSubjectToPossibleRedemptioninShares", "terseLabel": "Initial classification of Class A common stock subject to possible redemption (in Shares)" } } }, "localname": "InitialClassificationOfClassACommonStockSubjectToPossibleRedemptioninShares", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "sharesItemType" }, "amhc_InitialClassificationOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial classification of common stock subject to possible redemption.", "label": "InitialClassificationOfCommonStockSubjectToPossibleRedemption", "terseLabel": "Initial classification of Class A common stock subject to possible redemption" } } }, "localname": "InitialClassificationOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering [Abstract]" } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_InitialPublicOfferingDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering (Details) [Line Items]" } } }, "localname": "InitialPublicOfferingDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "amhc_InitialPublicOfferingDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering (Details) [Table]" } } }, "localname": "InitialPublicOfferingDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "amhc_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Public Offering.", "label": "InitialPublicOfferingTextBlock", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "amhc_InterestEarnedOnMarketableSecuritieHeldInTrustAccount": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The Amount of Interest earned on marketable securities held in Trust Account", "label": "InterestEarnedOnMarketableSecuritieHeldInTrustAccount", "terseLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InterestEarnedOnMarketableSecuritieHeldInTrustAccount", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "amhc_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest earned on marketable securities held in trust account.", "label": "InterestEarnedOnMarketableSecuritiesHeldInTrustAccount", "negatedLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InterestEarnedOnMarketableSecuritiesHeldInTrustAccount", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_InterestIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income.", "label": "InterestIncome", "terseLabel": "Interest Income" } } }, "localname": "InterestIncome", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "monetaryItemType" }, "amhc_LiabilitiesAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LiabilitiesAbstract0", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract0", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable0" ], "xbrltype": "stringItemType" }, "amhc_LossBasicAndDilutedNonRedeemableClassBCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "LossBasicAndDilutedNonRedeemableClassBCommonStock", "terseLabel": "Loss/Basic and Diluted Non-Redeemable Class B Common Stock (in Dollars per share)", "verboseLabel": "Earnings (Loss)/Basic and Diluted Non-Redeemable Class B Common Stock (in Dollars per share)" } } }, "localname": "LossBasicAndDilutedNonRedeemableClassBCommonStock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable", "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "perShareItemType" }, "amhc_NetEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net Earnings", "label": "NetEarnings", "terseLabel": "Net Earnings" } } }, "localname": "NetEarnings", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "monetaryItemType" }, "amhc_NetTangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net tangible assets.", "label": "NetTangibleAssets", "terseLabel": "Net tangible assets" } } }, "localname": "NetTangibleAssets", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "amhc_NonRedeemableClassBCommonStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NonRedeemableClassBCommonStockAbstract", "terseLabel": "Non-Redeemable Class B Common Stock" } } }, "localname": "NonRedeemableClassBCommonStockAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "amhc_NonRedeemableClassBCommonStockAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NonRedeemableClassBCommonStockAbstract0", "terseLabel": "Non-Redeemable Class B Common Stock" } } }, "localname": "NonRedeemableClassBCommonStockAbstract0", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "stringItemType" }, "amhc_NonRedeemableClassBCommonStockBasicAndDiluted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount Non-Redeemable common stock, Basic and Diluted.", "label": "NonRedeemableClassBCommonStockBasicAndDiluted", "terseLabel": "Non-Redeemable Class B Common Stock, Basic and Diluted" } } }, "localname": "NonRedeemableClassBCommonStockBasicAndDiluted", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable", "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "monetaryItemType" }, "amhc_NonRedeemableNetLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-Redeemable Net Loss.", "label": "NonRedeemableNetLoss", "terseLabel": "Non-Redeemable Net Loss", "verboseLabel": "Non-Redeemable Net (Loss) Income" } } }, "localname": "NonRedeemableNetLoss", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable", "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "monetaryItemType" }, "amhc_NumbersOfClassACommonStockSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Numbers of Class A common stock subject to redemption.", "label": "NumbersOfClassACommonStockSubjectToRedemption", "terseLabel": "Numbers of Class A common stock subject to redemption" } } }, "localname": "NumbersOfClassACommonStockSubjectToRedemption", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "monetaryItemType" }, "amhc_NumeratorEarningsAllocableToClassACommonStockSubjectToPossibleRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NumeratorEarningsAllocableToClassACommonStockSubjectToPossibleRedemptionAbstract", "terseLabel": "Numerator: Earnings allocable to Class A common stock subject to possible redemption" } } }, "localname": "NumeratorEarningsAllocableToClassACommonStockSubjectToPossibleRedemptionAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "stringItemType" }, "amhc_NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract", "terseLabel": "Numerator: Earnings allocable to Redeemable Class A Common Stock" } } }, "localname": "NumeratorEarningsAllocableToRedeemableClassACommonStockAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "amhc_NumeratorNetIncomeMinusRedeemableNetEarningsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NumeratorNetIncomeMinusRedeemableNetEarningsAbstract", "terseLabel": "Numerator: Net Income minus Redeemable Net Earnings" } } }, "localname": "NumeratorNetIncomeMinusRedeemableNetEarningsAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "stringItemType" }, "amhc_NumeratorNetLossIncomeMinusRedeemableNetEarningsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NumeratorNetLossIncomeMinusRedeemableNetEarningsAbstract", "terseLabel": "Numerator: Net (Loss) Income minus Redeemable Net Earnings" } } }, "localname": "NumeratorNetLossIncomeMinusRedeemableNetEarningsAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "amhc_OfferingCostsCharged": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of offering costs charge.", "label": "OfferingCostsCharged", "terseLabel": "Offering cost" } } }, "localname": "OfferingCostsCharged", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "amhc_OrganizationalCostsStartupExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Organizational costs/Startup expenses.", "label": "OrganizationalCostsStartupExpenses", "terseLabel": "Organizational costs/Startup expenses" } } }, "localname": "OrganizationalCostsStartupExpenses", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofnetdeferredtaxassetsTable" ], "xbrltype": "monetaryItemType" }, "amhc_PaymentOfOfferingCostThroughPromissoryNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of offering costs through promissory note.", "label": "PaymentOfOfferingCostThroughPromissoryNote", "terseLabel": "Payment of offering costs through promissory note \u2013 related party" } } }, "localname": "PaymentOfOfferingCostThroughPromissoryNote", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_PricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per warrant.", "label": "PricePerWarrant", "terseLabel": "Price per warrant (in Dollars per share)" } } }, "localname": "PricePerWarrant", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "amhc_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement [Abstract]" } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_PrivatePlacementDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement (Details) [Line Items]" } } }, "localname": "PrivatePlacementDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "amhc_PrivatePlacementDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement (Details) [Table]" } } }, "localname": "PrivatePlacementDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/PrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "amhc_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement.", "label": "PrivatePlacementTextBlock", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "amhc_PublicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PublicMember", "terseLabel": "Public [Member]" } } }, "localname": "PublicMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0" ], "xbrltype": "domainItemType" }, "amhc_PublicSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Share price.", "label": "PublicSharePrice", "terseLabel": "Public share price (in Dollars per share)" } } }, "localname": "PublicSharePrice", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "perShareItemType" }, "amhc_PublicStockholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PublicStockholdersMember", "terseLabel": "Public Stockholders [Member]" } } }, "localname": "PublicStockholdersMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "amhc_PublicWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PublicWarrantMember", "terseLabel": "Public [Member]", "verboseLabel": "Public Warrant [Member]" } } }, "localname": "PublicWarrantMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable" ], "xbrltype": "domainItemType" }, "amhc_RedeemableClassACommonStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RedeemableClassACommonStockAbstract", "terseLabel": "Redeemable Class A Common Stock" } } }, "localname": "RedeemableClassACommonStockAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "stringItemType" }, "amhc_RedeemableClassACommonStockBasicAndDiluted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of redeemable common stock, Basic and Diluted.", "label": "RedeemableClassACommonStockBasicAndDiluted", "terseLabel": "Redeemable Class A Common Stock, Basic and Diluted" } } }, "localname": "RedeemableClassACommonStockBasicAndDiluted", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable" ], "xbrltype": "monetaryItemType" }, "amhc_RedeemableClassACommonStockBasicAndDilutedinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RedeemableClassACommonStockBasicAndDilutedinShares", "terseLabel": "Redeemable Class A Common Stock, Basic and Diluted (in Shares)" } } }, "localname": "RedeemableClassACommonStockBasicAndDilutedinShares", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "sharesItemType" }, "amhc_RedeemableNetEarning": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "RedeemableNetEarning", "terseLabel": "Redeemable Net Earnings" } } }, "localname": "RedeemableNetEarning", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "monetaryItemType" }, "amhc_RedeemableNetEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redeemable Net Earnings.", "label": "RedeemableNetEarnings", "terseLabel": "Redeemable Net Earnings", "verboseLabel": "Less: Redeemable Net Earnings" } } }, "localname": "RedeemableNetEarnings", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable", "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "monetaryItemType" }, "amhc_RelatedPartyConsultingAgreementsFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of related party consulting agreements fee.", "label": "RelatedPartyConsultingAgreementsFee", "terseLabel": "Related party consulting agreements fee" } } }, "localname": "RelatedPartyConsultingAgreementsFee", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "amhc_RelatedPartyTransactionsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Line Items]" } } }, "localname": "RelatedPartyTransactionsDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "amhc_RelatedPartyTransactionsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "localname": "RelatedPartyTransactionsDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "amhc_RestatementToPriorYearBalanceSheetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of restatement to prior year balance sheet.", "label": "RestatementToPriorYearBalanceSheetTableTextBlock", "terseLabel": "Schedule of restatement of previously issued balance sheet" } } }, "localname": "RestatementToPriorYearBalanceSheetTableTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "amhc_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedbalancesheetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued balance sheet [Line Items]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedbalancesheetLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "stringItemType" }, "amhc_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedbalancesheetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued balance sheet [Table]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedbalancesheetTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "stringItemType" }, "amhc_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofcashflowsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of cash flows [Line Items]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofcashflowsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable" ], "xbrltype": "stringItemType" }, "amhc_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of cash flows [Table]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable" ], "xbrltype": "stringItemType" }, "amhc_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofoperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of operations [Line Items]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofoperationsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "stringItemType" }, "amhc_RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofoperationsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of previously issued statement of operations [Table]" } } }, "localname": "RestatementofPreviouslyIssuedFinancialStatementsDetailsScheduleofrestatementofpreviouslyissuedstatementofoperationsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "stringItemType" }, "amhc_SaleOfPrivatePlacementWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Private Placement Warrants", "label": "SaleOfPrivatePlacementWarrants", "terseLabel": "Excess of proceeds over the fair value of Private Placement Warrants" } } }, "localname": "SaleOfPrivatePlacementWarrants", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "amhc_SaleOfUnitsNetOfUnderwritingDiscountAndOfferingCost": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of Units, net of underwriting discount and offering costs", "label": "SaleOfUnitsNetOfUnderwritingDiscountAndOfferingCost", "terseLabel": "Sale of Units, net of underwriting discount and offering costs" } } }, "localname": "SaleOfUnitsNetOfUnderwritingDiscountAndOfferingCost", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3_Parentheticals" ], "xbrltype": "sharesItemType" }, "amhc_ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of basic and diluted net income (loss) per common share [Abstract]" } } }, "localname": "ScheduleOfBasicAndDilutedNetIncomeLossPerCommonShareAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of changes in the fair value of Level 3 warrant liabilities [Abstract]" } } }, "localname": "ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfFederalIncomeTaxRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of federal income tax rate [Abstract]" } } }, "localname": "ScheduleOfFederalIncomeTaxRateAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfIncomeTaxProvisionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of income tax provision [Abstract]" } } }, "localname": "ScheduleOfIncomeTaxProvisionAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfMeasuredAtFairValueOnARecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of measured at fair value on a recurring basis [Abstract]" } } }, "localname": "ScheduleOfMeasuredAtFairValueOnARecurringBasisAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfNetDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of net deferred tax assets [Abstract]" } } }, "localname": "ScheduleOfNetDeferredTaxAssetsAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of quantitative information regarding Level 3 fair value measurements [Abstract]" } } }, "localname": "ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfRestatementOfPreviouslyIssuedBalanceSheetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of restatement of previously issued balance sheet [Abstract]" } } }, "localname": "ScheduleOfRestatementOfPreviouslyIssuedBalanceSheetAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfRestatementOfPreviouslyIssuedStatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of restatement of previously issued statement of cash flows [Abstract]" } } }, "localname": "ScheduleOfRestatementOfPreviouslyIssuedStatementOfCashFlowsAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfRestatementOfPreviouslyIssuedStatementOfCashFlowsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of restatement to prior year statement of cash flows.", "label": "ScheduleOfRestatementOfPreviouslyIssuedStatementOfCashFlowsTableTextBlock", "terseLabel": "Schedule of restatement of previously issued statement of cash flows" } } }, "localname": "ScheduleOfRestatementOfPreviouslyIssuedStatementOfCashFlowsTableTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "amhc_ScheduleOfRestatementOfPreviouslyIssuedStatementOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of restatement of previously issued statement of operations [Abstract]" } } }, "localname": "ScheduleOfRestatementOfPreviouslyIssuedStatementOfOperationsAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_ScheduleOfRestatementOfPreviouslyIssuedStatementOfOperationsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of restatement of previously issued statement of operations.", "label": "ScheduleOfRestatementOfPreviouslyIssuedStatementOfOperationsTableTextBlock", "terseLabel": "Schedule of restatement of previously issued statement of operations" } } }, "localname": "ScheduleOfRestatementOfPreviouslyIssuedStatementOfOperationsTableTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "amhc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon stock price for the exchange of the underlying asset relating to the share-based payment award.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice", "terseLabel": "Stock price (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable", "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable0" ], "xbrltype": "perShareItemType" }, "amhc_ShareConversionPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Conversion percentage.", "label": "ShareConversionPercentage", "terseLabel": "Share conversion percentage" } } }, "localname": "ShareConversionPercentage", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "amhc_SharesSubjectToPossibleRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares subject to possible redemption.", "label": "SharesSubjectToPossibleRedemption", "terseLabel": "Class A common stock subject to possible redemption, outstanding", "verboseLabel": "Class A common stock subject to possible redemption" } } }, "localname": "SharesSubjectToPossibleRedemption", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "amhc_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SponsorMember", "terseLabel": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "amhc_StateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StateAbstract", "terseLabel": "State" } } }, "localname": "StateAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "stringItemType" }, "amhc_StatementOfCashFlowsForThePeriodFromAugust192019InceptionToDecember312019AuditedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StatementOfCashFlowsForThePeriodFromAugust192019InceptionToDecember312019AuditedAbstract", "terseLabel": "Statement of Cash Flows for the period from August 19, 2019 (inception) to December 31, 2019 (audited)" } } }, "localname": "StatementOfCashFlowsForThePeriodFromAugust192019InceptionToDecember312019AuditedAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "stringItemType" }, "amhc_StatementOfOperationsForTheYearEndedDecember312020AuditedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StatementOfOperationsForTheYearEndedDecember312020AuditedAbstract", "terseLabel": "Statement of Operations for the Year Ended December 31, 2020 (audited)" } } }, "localname": "StatementOfOperationsForTheYearEndedDecember312020AuditedAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "stringItemType" }, "amhc_StockConversionPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "converted basis.", "label": "StockConversionPercentage", "terseLabel": "Converted stock percentage" } } }, "localname": "StockConversionPercentage", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "amhc_StockDuringPeriodForCommonStockSubjectToPossibleRedemptionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock during period for common stock subject to possible redemption shares.", "label": "StockDuringPeriodForCommonStockSubjectToPossibleRedemptionShares", "terseLabel": "Change in value of Class A common stock subject to possible redemption (in Shares)" } } }, "localname": "StockDuringPeriodForCommonStockSubjectToPossibleRedemptionShares", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "amhc_StockIssuedDuringPeriodSharesNewIssue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "StockIssuedDuringPeriodSharesNewIssue", "terseLabel": "Issuance of common stock to sponsor (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssue", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "amhc_StockIssuedDuringSaleOfPrivatePlacementWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during sale of private placement warrants shares.", "label": "StockIssuedDuringSaleOfPrivatePlacementWarrantsShares", "terseLabel": "Excess of proceeds over the fair value of Private Placement Warrants (in Shares)" } } }, "localname": "StockIssuedDuringSaleOfPrivatePlacementWarrantsShares", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "amhc_StockholdersEquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) [Line Items]" } } }, "localname": "StockholdersEquityDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "amhc_StockholdersEquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) [Table]" } } }, "localname": "StockholdersEquityDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "amhc_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "amhc_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "amhc_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "amhc_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "amhc_TransactionCostAllocatedToWarrantLiability": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs allocated to warrant liability.", "label": "TransactionCostAllocatedToWarrantLiability", "terseLabel": "Transaction costs allocated to warrant liability" } } }, "localname": "TransactionCostAllocatedToWarrantLiability", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "amhc_TransactionCostsAllocatedToWarrantLiability": { "auth_ref": [], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs allocated to warrant liability.", "label": "TransactionCostsAllocatedToWarrantLiability", "negatedLabel": "Transaction costs allocated to warrant liability", "negatedTerseLabel": "Transaction costs allocated to warrant liability" } } }, "localname": "TransactionCostsAllocatedToWarrantLiability", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "amhc_TransactionCostsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs amount.", "label": "TransactionCostsAmount", "terseLabel": "Transaction costs amount" } } }, "localname": "TransactionCostsAmount", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "amhc_TypeOfAgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type Of Agreement", "label": "TypeOfAgreementAxis", "terseLabel": "Type Of Agreement [Axis]" } } }, "localname": "TypeOfAgreementAxis", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "amhc_TypeOfAgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TypeOfAgreement [Domain]" } } }, "localname": "TypeOfAgreementDomain", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "amhc_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting Agreement.", "label": "UnderwritingAgreementMember", "terseLabel": "Underwriting Agreement [Member]" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "amhc_WarrantLiabilitiesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liabilities (Details) [Line Items]" } } }, "localname": "WarrantLiabilitiesDetailsLineItems", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "amhc_WarrantLiabilitiesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liabilities (Details) [Table]" } } }, "localname": "WarrantLiabilitiesDetailsTable", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "amhc_WarrantLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantLiabilitiesMember", "terseLabel": "Level 3 Warrant Liabilities [Member]" } } }, "localname": "WarrantLiabilitiesMember", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0" ], "xbrltype": "domainItemType" }, "amhc_WarrantLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability [Abstract]" } } }, "localname": "WarrantLiabilityAbstract", "nsuri": "http://Amplitudehealthcare.com/20210630", "xbrltype": "stringItemType" }, "amhc_WarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for warrant liability.", "label": "WarrantLiabilityPolicyTextBlock", "terseLabel": "Warrant Liabilities" } } }, "localname": "WarrantLiabilityPolicyTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "amhc_WarrantLiabilityPrivatePlacementWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liability private placement warrants.", "label": "WarrantLiabilityPrivatePlacementWarrants", "terseLabel": "Warrant Liability \u2013 Private Placement Warrants", "verboseLabel": "Warrant liability \u2013 Private Placement Warrants" } } }, "localname": "WarrantLiabilityPrivatePlacementWarrants", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable", "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable0" ], "xbrltype": "monetaryItemType" }, "amhc_WarrantLiabilityPublicWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liability public warrants.", "label": "WarrantLiabilityPublicWarrants", "terseLabel": "Warrant Liability \u2013 Public Warrants", "verboseLabel": "Warrant liability \u2013 Public Warrants" } } }, "localname": "WarrantLiabilityPublicWarrants", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable", "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable0" ], "xbrltype": "monetaryItemType" }, "amhc_WarrantLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure warrant liability.", "label": "WarrantLiabilityTextBlock", "terseLabel": "WARRANT LIABILIES" } } }, "localname": "WarrantLiabilityTextBlock", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilities" ], "xbrltype": "textBlockItemType" }, "amhc_WeightedAverageNumberOfSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "terseLabel": "Weighted average shares outstanding of Class A redeemable common stock (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "sharesItemType" }, "amhc_WeightedAverageSharesOutstandingOfClassBNonredeemableCommonStockinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "WeightedAverageSharesOutstandingOfClassBNonredeemableCommonStockinShares", "terseLabel": "Weighted average shares outstanding of Class B non-redeemable common stock (in Shares)" } } }, "localname": "WeightedAverageSharesOutstandingOfClassBNonredeemableCommonStockinShares", "nsuri": "http://Amplitudehealthcare.com/20210630", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "sharesItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://Amplitudehealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief executive officer.", "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Financial Information Disclosure [Abstract]" } } }, "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract", "nsuri": "http://fasb.org/srt/2021-01-31", "xbrltype": "stringItemType" }, "srt_CondensedFinancialStatementsTextBlock": { "auth_ref": [ "r68", "r318", "r319", "r320", "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for condensed financial statements.", "label": "Condensed Financial Statements [Text Block]", "terseLabel": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" } } }, "localname": "CondensedFinancialStatementsTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RestatementofPreviouslyIssuedFinancialStatements" ], "xbrltype": "textBlockItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r70", "r71", "r72", "r73", "r74", "r75", "r76", "r78", "r80", "r81", "r83", "r84", "r95", "r239", "r240" ], "lang": { "en-us": { "role": { "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Restatement [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r70", "r71", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r80", "r81", "r82", "r83", "r84", "r85", "r95", "r124", "r125", "r191", "r209", "r238", "r239", "r240", "r241", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "stringItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r1", "r70", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r80", "r81", "r83", "r84", "r95", "r124", "r125", "r191", "r209", "r238", "r239", "r240", "r241", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Previously Reported [Member]", "terseLabel": "As Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r119", "r269" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r14", "r191", "r275" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "verboseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r70", "r71", "r72", "r188", "r189", "r190", "r239" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net (loss) income to net cash used in operating activities:", "verboseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r62", "r111", "r113", "r117", "r122", "r134", "r135", "r136", "r138", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r223", "r229", "r251", "r273", "r275", "r284", "r293" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r8", "r29", "r62", "r122", "r134", "r135", "r136", "r138", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r223", "r229", "r251", "r273", "r275" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Assets Held-in-trust", "terseLabel": "Marketable securities held in Trust Account" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Marketable securities held in Trust Account \u2013 U.S. Treasury Securities Money Market Fund" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable", "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable0" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r181", "r182" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r181", "r182", "r220", "r221" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition, Transaction Costs", "terseLabel": "Transaction costs amount" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationControlObtainedDescription": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "This element represents a description of how the entity obtained control of the acquired entity.", "label": "Business Combination, Control Obtained Description", "terseLabel": "Business combination, description" } } }, "localname": "BusinessCombinationControlObtainedDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationReasonForBusinessCombination": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "This element represents a description of the primary reason for the business combination which may consist of general categories such as top-line growth, synergistic benefits, market share, and diversification and the more detailed factors that might apply.", "label": "Business Combination, Reason for Business Combination", "terseLabel": "Business combination, description" } } }, "localname": "BusinessCombinationReasonForBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage", "terseLabel": "Business combination, percentage" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r19", "r55" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash \u2013 End of period", "periodStartLabel": "Cash \u2013 Beginning of period", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r10", "r56" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r49", "r252" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Change in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Federal depository insurance coverage" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:", "verboseLabel": "Supplemental disclosure of non-cash activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r60", "r62", "r86", "r87", "r88", "r90", "r92", "r97", "r98", "r99", "r122", "r134", "r139", "r140", "r141", "r145", "r146", "r155", "r156", "r158", "r162", "r251", "r317" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails", "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r26", "r132", "r286", "r296" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r129", "r130", "r131", "r133", "r315" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Class A Common Stock [Member]", "netLabel": "Class A", "terseLabel": "Class A Common Stock", "verboseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails", "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "netLabel": "Class B Common Stock [Member]", "terseLabel": "Class B Common Stock", "verboseLabel": "Class B" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r70", "r71", "r239" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, share authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r13", "r168" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r13", "r275" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock value", "verboseLabel": "Class A Common Stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonUnitIssued": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Number of common units issued of limited liability company (LLC).", "label": "Common Unit, Issued", "terseLabel": "Sale of unit (in Shares)" } } }, "localname": "CommonUnitIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r103", "r292" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r58", "r225" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r63", "r205", "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r63", "r205", "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r147", "r150", "r151", "r260", "r262", "r263" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate loan amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r25", "r148", "r244" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Non-interest bearing maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Offering Costs" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r63", "r206", "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Deferred" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r261" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Other offering costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredLeasingCommissions": { "auth_ref": [ "r264" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized fee revenue received at the inception of a lease that is deferred and recognized over the life of the lease.", "label": "Deferred Leasing Commissions", "terseLabel": "Deferred aggregate amount" } } }, "localname": "DeferredLeasingCommissions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r28", "r128" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred Offering Costs", "terseLabel": "Offering cost" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r63", "r206", "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "Deferred" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r200" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "terseLabel": "Total deferred tax asset" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofnetdeferredtaxassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r202" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Deferred tax asset, net of allowance" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofnetdeferredtaxassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r201" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofnetdeferredtaxassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r30", "r31", "r32", "r250" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Warrant liability", "verboseLabel": "Warrant Liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r67", "r233", "r234", "r235", "r236", "r237" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net income (loss) per share (in Dollars per share)", "verboseLabel": "Basic and diluted net loss per share, Class A (in Dollars per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r93", "r94" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net income (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Income tax provision" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleoffederalincometaxrateTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r64", "r196", "r213" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleoffederalincometaxrateTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r196", "r213" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleoffederalincometaxrateTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r196", "r213" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleoffederalincometaxrateTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r196", "r213" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State taxes, net of federal tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleoffederalincometaxrateTable" ], "xbrltype": "percentItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r36", "r37", "r38", "r70", "r71", "r72", "r74", "r81", "r84", "r96", "r123", "r168", "r170", "r188", "r189", "r190", "r208", "r209", "r239", "r253", "r254", "r255", "r256", "r257", "r258", "r303", "r304", "r305", "r325" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership interest, percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r53", "r152" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "terseLabel": "Change in fair value of warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r242", "r243" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r149", "r150", "r151", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r180", "r243", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r149", "r172", "r173", "r178", "r180", "r243", "r279" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]", "verboseLabel": "Fair Value Inputs Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r242", "r243" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.", "label": "Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]", "terseLabel": "Schedule of changes in the fair value of Level 3 warrant liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of quantitative information regarding Level 3 fair value measurements" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.", "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueMeasurementInputsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Transfer amount of fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r149", "r150", "r151", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r180", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r247", "r249" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "Initial Public Offering [Member]", "verboseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r39", "r111", "r112", "r115", "r116", "r118", "r283", "r287", "r290", "r299" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "(Loss) Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r64", "r197", "r198", "r204", "r210", "r214", "r216", "r217", "r218" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAX" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/IncomeTax" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r65", "r83", "r84", "r110", "r195", "r211", "r215", "r300" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Benefit from (Provision for) income taxes", "terseLabel": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r35", "r193", "r194", "r198", "r199", "r203", "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r196" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r52" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r52" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r52" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid income taxes" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r52" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "negatedLabel": "Less: Income and Franchise Tax available to be withdrawn from the Trust Account" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyRedemptionFeePerShare": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of fee charged to investor for redemption of shares before permitted period.", "label": "Investment Company, Redemption Fee, Per Share", "terseLabel": "Deferred fee, per unit (in Dollars per share)" } } }, "localname": "InvestmentCompanyRedemptionFeePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r62", "r114", "r122", "r134", "r135", "r136", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r224", "r229", "r230", "r251", "r273", "r274" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofmeasuredatfairvalueonarecurringbasisTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r18", "r62", "r122", "r251", "r275", "r285", "r295" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r24", "r62", "r122", "r134", "r135", "r136", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r224", "r229", "r230", "r251", "r273", "r274", "r275" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r242" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "periodEndLabel": "Fair value, ending balance", "periodStartLabel": "Fair value, beginning balance" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesNoncurrent": { "auth_ref": [ "r20" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as noncurrent.", "label": "Marketable Securities, Noncurrent", "terseLabel": "Investments held in Trust Account" } } }, "localname": "MarketableSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r100", "r109" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r49" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r49" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r49", "r51", "r54" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r33", "r34", "r38", "r40", "r54", "r62", "r73", "r75", "r76", "r78", "r79", "r83", "r84", "r89", "r111", "r112", "r115", "r116", "r118", "r122", "r134", "r135", "r136", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r241", "r251", "r288", "r298" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net (loss) income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow", "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofcashflowsTable", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r154", "r227", "r228" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net (Loss) Income" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable", "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoninterestIncome": { "auth_ref": [ "r289" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of noninterest income which may be derived from: (1) fees and commissions; (2) premiums earned; (3) insurance policy charges; (4) the sale or disposal of assets; and (5) other sources not otherwise specified.", "label": "Noninterest Income", "terseLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "NoninterestIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofbasicanddilutednetincomelosspercommonshareTable0" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r66", "r268", "r297" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes Payable, Related Parties", "terseLabel": "Outstanding promissory note payable" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r111", "r112", "r115", "r116", "r118" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r43", "r302" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "terseLabel": "Other expenses" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r301" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "totalLabel": "Total other (expense) income, net" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other Intangible Assets, Net", "terseLabel": "Net tangible assets" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInterestEarningAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest earning assets classified as other.", "label": "Other Interest Earning Assets", "terseLabel": "Interest earned" } } }, "localname": "OtherInterestEarningAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r4", "r7", "r127" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherUnderwritingExpense": { "auth_ref": [ "r302", "r313" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.", "label": "Other Underwriting Expense", "terseLabel": "Deferred underwriting fees" } } }, "localname": "OtherUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent", "terseLabel": "Aggregate office space amount" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Payments for Underwriting Expense", "terseLabel": "Underwriting fees", "verboseLabel": "Underwriters aggregate amount" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r47" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r12", "r155" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock, share authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r12", "r155" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, share issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, share outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r12", "r275" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r5", "r7", "r126", "r127" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Taxes", "terseLabel": "Prepaid income taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]", "verboseLabel": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "terseLabel": "Net proceeds" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Generating gross proceeds" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r44" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from sale of Units, net of underwriting discounts paid", "verboseLabel": "Aggregate gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow", "http://Amplitudehealthcare.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r44" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "netLabel": "Aggregate purchase price (in Dollars)", "terseLabel": "Proceeds from sale of Private Placement Warrants", "verboseLabel": "Gross proceeds of warrants" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow", "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r33", "r34", "r38", "r48", "r62", "r73", "r83", "r84", "r111", "r112", "r115", "r116", "r118", "r122", "r134", "r135", "r136", "r139", "r140", "r141", "r142", "r143", "r145", "r146", "r222", "r226", "r228", "r231", "r232", "r241", "r251", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income/ loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyCosts": { "auth_ref": [ "r41", "r66", "r137", "r139", "r140", "r144", "r145", "r146" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.", "label": "Related Party Costs", "terseLabel": "Incurred and paid under agreement" } } }, "localname": "RelatedPartyCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r267", "r270" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related Party Transaction, Amounts of Transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r179", "r267", "r268", "r270" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r267" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Incurred and paid fees" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r265", "r266", "r268", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r46" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of promissory note \u2013 related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r15", "r170", "r191", "r275", "r294", "r307", "r312" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "verboseLabel": "(Accumulated Deficit) Retained Earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r70", "r71", "r72", "r74", "r81", "r84", "r123", "r188", "r189", "r190", "r208", "r209", "r239", "r303", "r305" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings/(Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Aggregate consideration" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "netLabel": "Sale of warrants (in Shares)", "terseLabel": "Sale of warrants ( (in Shares)", "verboseLabel": "Sale of units (in Shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "netLabel": "Sale price per unit", "terseLabel": "Sale price (in Dollars per share)", "verboseLabel": "Unit price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of income tax provision" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of net deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of basic and diluted net income (loss) per common share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of federal income tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Business Combination [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable", "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable0" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility", "verboseLabel": "Volatilty" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable", "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable0" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free rate", "verboseLabel": "Aggregate fair market value percentage" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable", "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable0" ], "xbrltype": "percentItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "netLabel": "Common stock price per share", "terseLabel": "Share price per unit (in Dollars per share)", "verboseLabel": "Stock price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails", "http://Amplitudehealthcare.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r183", "r192" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Term to initial business combination (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable", "http://Amplitudehealthcare.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable0" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Common stock subject to possible redemption (in Shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Initial public offering price per unit (in Dollars per share)", "verboseLabel": "Common stock price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r57", "r69" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r11", "r12", "r13", "r60", "r62", "r86", "r87", "r88", "r90", "r92", "r97", "r98", "r99", "r122", "r134", "r139", "r140", "r141", "r145", "r146", "r155", "r156", "r158", "r162", "r168", "r251", "r317" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/CommitmentsandContingenciesDetails", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3", "http://Amplitudehealthcare.com/role/StockholdersEquityDetails", "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r27", "r36", "r37", "r38", "r70", "r71", "r72", "r74", "r81", "r84", "r96", "r123", "r168", "r170", "r188", "r189", "r190", "r208", "r209", "r239", "r253", "r254", "r255", "r256", "r257", "r258", "r303", "r304", "r305", "r325" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r70", "r71", "r72", "r96", "r282" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Founder shares issued and outstanding (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r12", "r13", "r168", "r170" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of Class B common stock to Sponsor (in Shares)", "verboseLabel": "Issuance of common stock to sponsor (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Sale of 10,000,000 Units, net of underwriting discount, offering costs and fair value of Public Warrants (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Forfeiture of Class B common stock by Sponsor (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r12", "r13", "r168", "r170" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of Class B common stock to Sponsor" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Sale of 10,000,000 Units, net of underwriting discount, offering costs and fair value of Public Warrants" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Forfeiture of Class B common stock by Sponsor" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Shares", "negatedLabel": "Class A common stock subject to possible redemption (in Shares)" } } }, "localname": "StockRedeemedOrCalledDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r168" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value", "negatedLabel": "Class A common stock subject to possible redemption" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r13", "r16", "r17", "r62", "r120", "r122", "r251", "r275" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Total Stockholders\u2019 Equity", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable", "http://Amplitudehealthcare.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r61", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r170", "r171" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r259", "r277" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r259", "r277" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r276", "r278" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails", "http://Amplitudehealthcare.com/role/InitialPublicOfferingDetails", "http://Amplitudehealthcare.com/role/PrivatePlacementDetails", "http://Amplitudehealthcare.com/role/RelatedPartyTransactionsDetails", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable", "http://Amplitudehealthcare.com/role/ScheduleofchangesinthefairvalueofLevel3warrantliabilitiesTable0", "http://Amplitudehealthcare.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r134", "r139", "r140", "r141", "r145", "r146" ], "calculation": { "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Class A common stock subject to possible redemption", "verboseLabel": "Class A Common Stock Subject to Possible Redemption" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet", "http://Amplitudehealthcare.com/role/ScheduleofrestatementofpreviouslyissuedbalancesheetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r9", "r153" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Common stock, share (in Dollars per share)" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r9", "r153" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Common stock exceeds per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r101", "r102", "r104", "r105", "r106", "r107", "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Change in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/IncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantExercisePriceDecrease": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.", "label": "Warrant, Exercise Price, Decrease", "terseLabel": "Warrant price per share" } } }, "localname": "WarrantExercisePriceDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/DescriptionofOrganizationandBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants and Rights Outstanding, Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/WarrantLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Weighted average shares outstanding (in Shares)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://Amplitudehealthcare.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r131": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r133": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "http://asc.fasb.org/topic&trid=2155941" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(4)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123392090&loc=d3e45377-112738" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r278": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.13)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "720", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=35755714&loc=d3e28434-158551" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r316": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r317": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r318": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "a", "Publisher": "SEC", "Section": "12", "Subsection": "04" }, "r319": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r320": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "d", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r321": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "e", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r322": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "f", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r323": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" } }, "version": "2.1" }